About this episode
On Sunday, July 28, 2024, at 1 p.m. U.S. Pacific Time, the U.S. Transhumanist Party invites Dr. Abdelhadi Rebbaa to discuss his views regarding the potential and limitations for using senolytics to treat aging and go over alternative/complementary approaches to delay senescence onset.
Dr. Abdelhadi Rebbaa received his PhD in Biochemistry from the Université Claude Bernard, Lyon, France. He held research and faculty positions at Northwestern University, the University of Pittsburgh, and Columbia University. Over the course of his career, his research encompassed target and drug discovery and development in the fields of cancer, stem cells, and aging. He served as a Principal Investigator on multiple grants, published over 40 manuscripts, and reviewed manuscripts for several high-impact scientific journals. In his role at Ichor Therapeutics from 2018 to 2021, he oversaw the discovery and preclinical testing of small-molecule senolytics and biomarkers of aging. He then worked for SENS Research Foundation between January 2022 and January 2024, where his role was to conceive, design, and oversee research projects on senescence prevention, senolytics, and partial reprogramming. Now he works as a Project Management Consultant in New Jersey.
See Dr. Abdelhadi Rebbaa’s LinkedIn profile: https://www.linkedin.com/in/abdelhadi-rebbaa-32bb9279/
Dr. Abdelhadi Rebbaa received his PhD in Biochemistry from the Université Claude Bernard, Lyon, France. He held research and faculty positions at Northwestern University, the University of Pittsburgh, and Columbia University. Over the course of his career, his research encompassed target and drug discovery and development in the fields of cancer, stem cells, and aging. He served as a Principal Investigator on multiple grants, published over 40 manuscripts, and reviewed manuscripts for several high-impact scientific journals. In his role at Ichor Therapeutics from 2018 to 2021, he oversaw the discovery and preclinical testing of small-molecule senolytics and biomarkers of aging. He then worked for SENS Research Foundation between January 2022 and January 2024, where his role was to conceive, design, and oversee research projects on senescence prevention, senolytics, and partial reprogramming. Now he works as a Project Management Consultant in New Jersey.
See Dr. Abdelhadi Rebbaa’s LinkedIn profile: https://www.linkedin.com/in/abdelhadi-rebbaa-32bb9279/
Get every episode summarized
Each time Transhumanist Party Enlightenment Salon publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Transhumanist Party Enlightenment Salon
Adam Czajkowski
Transhumanist Party Enlightenment Salon
Jan 4, 20261:55:39pending
David Primer
Transhumanist Party Enlightenment Salon
Dec 28, 20251:56:41pending
TransVision Madrid 2025 Summit
Transhumanist Party Enlightenment Salon
Dec 21, 20251:50:21pending
Brandon King
Transhumanist Party Enlightenment Salon
Dec 14, 20252:00:52pending